Mindful Health Solutions

What Mindful Health Solutions does

Mindful Health Solutions is a California-based behavioral healthcare provider specializing in interventional psychiatry for treatment-resistant depression and other mood and anxiety disorders. Founded in 2007 and headquartered in San Francisco, the company operates 21 outpatient mental health clinics across California, Texas, and Washington, staffed by board-certified psychiatrists and interventional specialists. Its core treatment portfolio comprises Transcranial Magnetic Stimulation (TMS), SPRAVATO (esketamine) nasal spray, and IV Ketamine Infusion Therapy, supplemented by medication management and telehealth services. In June 2025 the company acquired and implemented MindfulONE, a proprietary one-day TMS protocol that condenses standard multi-week treatment into a single day with reported 70% remission rates.

The company operates a clinically rigorous, physician-led care model anchored by one of the largest TMS and esketamine patient outcome repositories in the U.S. — over 1 million data points from 50,000+ patients across 300,000+ visits — used to develop predictive algorithms for treatment success. It is the second-largest administrator of SPRAVATO nationally and has administered more than 300,000 interventional treatments to over 100,000 patients with a reported 80% symptom improvement rate across its population. Operational technology includes a NextGen patient portal and a Sohar Health insurance eligibility integration (94.17% automation rate across three states).

Mindful Health Solutions generates revenue primarily through insurance reimbursement from major commercial and government payers (Aetna, Anthem, Cigna, Optum/United Health Care, Blue Cross Blue Shield, Kaiser Permanente, Medicare), with a dedicated Patient Access Team handling pre-authorization, benefits investigation, and financing. The MindfulONE self-pay protocol is priced at approximately $5,000 per course with CareCredit financing options. Distribution relies on a hybrid referral-plus-direct-to-consumer model: referring psychiatrists, primary care providers, and therapists send patients needing advanced interventional treatments, while the company's website, self-scheduling portal, and phone intake support direct patient acquisition. The company is privately held and structured as a California Professional Corporation, with no publicly disclosed parent company or institutional majority owner identified in available data.

Name

Mindful Health Solutions

Legal name

Mindful Health Solutions

Website

https://mindfulhealthsolutions.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

Mindful Health Solutions operates 21 outpatient clinics across California, Texas, and Washington providing interventional psychiatric treatments — TMS, SPRAVATO (esketamine), and IV Ketamine — primarily for patients with treatment-resistant depression and mood or anxiety disorders, supported by telehealth and a proprietary patient outcome data repository.

Ownership category

akta.pro rank

Product category

Interventional Psychiatry Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

akta.pro secondary industry

Outpatient Mental Health & Counseling Clinics (HLAFABAC)

Keywords

• Interventional psychiatry
• Transcranial magnetic stimulation
• Esketamine treatment
• Ketamine infusion therapy
• Behavioral health services

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices20 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

1. Interventional Psychiatry Services: Revenue generated from delivering TMS therapy, SPRAVATO (esketamine) nasal spray, IV Ketamine Infusion Therapy, and medication management services across 21 outpatient clinic locations in California, Texas, and Washington. Services are billed per treatment course or session. Insurance-based model where the company advocates for coverage and processes claims through a dedicated Patient Access Team.
2. Insurance Reimbursement: TMS therapy and SPRAVATO nasal spray are covered by most major health insurance plans. The company performs benefits investigation, obtains insurance pre-authorization, and submits and processes claims for all therapies. When coverage is not approved, the Patient Access Team provides financing options and financial assistance.
3. Self-Pay / Out-of-Pocket Treatment: MindfulONE one-day TMS protocol priced at approximately $5,000 for self-pay patients. CareCredit payment plans offered from 6-60 months, with payments as low as $135 per month. Covers patients without insurance or those whose insurance does not cover specific protocols.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mindful Health Solutions provides interventional psychiatric treatments for treatment-resistant depression and other mood and anxiety disorders. Core offerings include Transcranial Magnetic Stimulation (TMS) therapy (including a proprietary one-day MindfulONE protocol), SPRAVATO (esketamine) nasal spray, and IV Ketamine Infusion Therapy, delivered across 21 outpatient clinics in California, Texas, and Washington and via telehealth. Services are delivered by board-certified psychiatrists with comprehensive insurance advocacy and financing support.

Product overview

Mindful Health Solutions operates as a behavioral health care platform offering interventional psychiatric treatments for treatment-resistant depression and other mood/anxiety disorders. The core treatment portfolio includes Transcranial Magnetic Stimulation (TMS) therapy with its proprietary MindfulONE one-day protocol, SPRAVATO (esketamine) nasal spray, and IV Ketamine Infusion Therapy, supplemented by medication management and telehealth services. The company pioneered TMS-focused clinics in the U.S., holds one of the largest TMS and Esketamine patient outcome repositories (1 million+ data points from 50,000+ patients), and operates 21 outpatient clinics across California, Texas, and Washington.

Differentiator

Problem solved

Functional benefit

Brands

• MindfulONE: A breakthrough one-day TMS therapy protocol that delivers rapid, durable relief for depression in just one day, condensing weeks of therapy into a single treatment session with 70% patient remission rates

Products and services

• Transcranial Magnetic Stimulation (TMS) Therapy Non-invasive FDA-approved procedure using targeted electromagnetic pulses to stimulate brain regions with reduced activity, releasing neurotransmitters such as serotonin and dopamine for treatment-resistant depression. FDA-approved for major depressive disorder (2008) and adolescents ages 15+ (2019). Effective in approximately 63% of patients at Mindful Health Solutions.
• MindfulONE One-Day TMS Proprietary one-day TMS protocol that condenses a traditional 36-session course into a single day using pharmacologically augmented accelerated TMS with two pre-treatment medications to enhance brain plasticity. 70% of patients achieve full remission, with most patients experiencing full treatment effects within 1 to 6 weeks. Available at select clinics including Mission Viejo, San Francisco, Sacramento, Seattle, and Houston.
• SPRAVATO (Esketamine) Therapy FDA-approved prescription esketamine nasal spray for treatment-resistant depression, thought to create new neural connections that reduce depression symptoms. Effective in approximately 70% of patients. Covered by most major insurance plans with advocacy provided by the Patient Access Team.
• Ketamine Infusion Therapy (IV Ketamine) Intravenous ketamine treatment that stimulates rapid glutamate increase in the brain for severe treatment-resistant depression, PTSD, and other psychiatric conditions. Effective in approximately 49% of patients, with rapid symptom improvement. Delivered by board-certified psychiatrists at select clinic locations.
• Medication Management Expert psychiatric evaluation and ongoing medication support as part of a comprehensive care plan, available via in-person or virtual appointments. Serves patients with major depressive disorder, generalized anxiety disorder, OCD, bipolar disorder, PTSD, and ADHD.
• Telehealth Services (Telepsychiatry) Virtual psychiatric appointments allowing patients to access mental health care remotely, including initial assessments, follow-ups, ongoing medication management, and California Telepsychiatry. Expands access across California, Texas, and Washington through virtual care delivery.
• Accelerated TMS Treatment delivering multiple TMS sessions in one day to lessen the logistical burden on patients and potentially shorten time to treatment response. Condenses the traditional 36-treatment course delivered daily over 6 weeks into fewer sessions as part of broader accelerated TMS offerings.

Quantifiable outcome

• 80% symptom improvement across patient population
• +7 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Sohar HealthcoreTechnology or Integration · 6 November 2025Sohar Health partnered with Mindful Health Solutions to implement its eligibility verification system across three states. The integration automates insurance verification with a 94.17% automation rate, reducing manual checks and streamlining patient intake operations. The partnership improves accuracy and efficiency in insurance eligibility processes, providing greater financial clarity to patients while reducing administrative burden for the practice.

Scale indicators12 records

Recent moves10 records

Expansion highlights5 records

Others

• Neuronetics: Manufacturer of the NeuroStar TMS device used by many U.S. outpatient psychiatry clinics including Mindful Health Solutions. Relevant as enabling infrastructure/ecosystem participant whose device penetration and clinical evidence directly shape TMS adoption economics for clinic operators like MHS.

Emerging players

• KetaMD: At-home ketamine telemedicine provider offering oral and injectable ketamine protocols for depression and anxiety. Competes for the same treatment-resistant patient segment using ketamine pharmacology, but substitutes in-clinic infusion with telehealth delivery.
• Brightside Health: Online mental health platform combining telehealth psychiatry with at-home TMS (using a wearable device) for treatment-resistant depression. Competes for the same TRD patient segment and is pushing into interventional treatments, making it a credible adjacent and partial-direct competitor.
• Joyous: Telehealth provider offering low-dose ketamine treatment via sublingual lozenges for depression, anxiety, and PTSD. Targets a comparable patient demographic seeking ketamine-based alternatives, though it does not offer TMS or esketamine.
• Cerebral: Large national online mental health subscription service offering medication management and therapy, including for treatment-resistant depression. Overlaps on target patient population but delivers care virtually and does not operate in-clinic interventional treatment suites.
• Talkiatry: Tech-enabled telepsychiatry practice staffed by board-certified psychiatrists delivering medication management and evaluation virtually. Comparable in serving adult mental health patients with psychiatrist-led care, but primarily virtual and not offering in-clinic TMS/esketamine/ketamine protocols.

Regional players

• Pacific Neuropsychiatric Specialists: Multi-specialty outpatient psychiatric group operating across Southern California offering TMS, esketamine, and medication management. Comparable on in-clinic interventional psychiatry model and overlapping California geography, though broader in services (addiction, neurology, child psychiatry).

Direct peers

• Greenbrook TMS (TMS & Brain Health): One of the largest dedicated TMS clinic networks in North America, operating 100+ outpatient locations focused on transcranial magnetic stimulation for depression. Most direct comparable on interventional psychiatry scale, clinic-based delivery model, and payer-reimbursement-dependent economics.
• Apollo TMS / Behavioral Health Group: Multi-state outpatient clinic network offering TMS, esketamine, and ketamine infusion therapy for treatment-resistant depression. Operates with a similar referral-driven, insurance-reimbursed interventional psychiatry model across the western and central U.S.
• Klarity Clinic: Outpatient interventional psychiatry provider offering TMS, esketamine (SPRAVATO), and ketamine infusion therapy in multiple states. Directly comparable on treatment modalities, patient population (TRD, anxiety, mood disorders), and clinic-based delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@MindfulHealthSolutions
• Facebookfacebook.com/tmshealthsolutions
• LinkedInlinkedin.com/company/3650966
• Instagraminstagram.com/mindful.health.solutions
• TikToktiktok.com/@mindfulhealthsolutions
• Xx.com/TMS_Health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mindful Health Solutions